Oral cancer is an increasingly prevalent disease worldwide, with over 300,000 new cases diagnosed each year. Among oral cancers, tongue cancer (TC) is the most common type and often carries a poor prognosis. Surgery combined with chemoradiotherapy is one of the main lines of treatment for high-risk cases of TC.
MHRA seeks input on new regulatory guidance for cancer vaccines – Pharmaceutical Technology
Investigational mRNA vaccines are manufactured for individuals based on the specific molecular features of their tumours. Credit: FatCamera via Getty Images. The UK’s drug regulatory
February 3, 2025